arrow
O

Olaf Heidenreich

princess maxima center for pediatric oncology
H指数:48
被引数:8,886

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mitochondria transfer via tunneling nanotubes drives macrophage immunosuppression and metabolic reprogramming in pediatric AML

通过隧道纳米管介导的线粒体转移驱动儿童急性髓系白血病中巨噬细胞的免疫抑制和代谢重编程

Leukemia
IF13.4
2026-10-090
OAAI
Single-cell multiomic atlas of healthy pediatric bone marrow reveals age-dependent differences in lineage differentiation driven by stromal signaling

健康小儿骨髓的单细胞多组图谱揭示了基质信号驱动的谱系分化的年龄依赖性差异

2026-02-170
OAAI
The glycosaminoglycan oncofetal chondroitin sulfate represents a novel target for antibody-drug conjugate therapy for AML

糖胺聚糖中的肿瘤胎儿性硫酸软骨素代表了一种针对AML的抗体药物偶联物疗法的新靶点。

Blood
IF23.1
2025-12-190
PRE
Bone marrow lymphocyte dynamics during chemotherapy in pediatric acute myeloid leukemia

化疗期间儿童急性髓系白血病患者骨髓淋巴细胞动力学

2025-09-120
PREAI
A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia
LEUKEMIA
IF13.4
2024-08-261
OAAI
ITCC-P4, a preclinical proof-of-concept drug testing platform as a tool for pharmacological screening in pediatric tumor models

ITCC-P4,一个临床前概念验证药物测试平台,作为儿科肿瘤模型药理筛选的工具

2024-03-220
PRE